The shadow of generic competition has consistently loomed over copyright’s iconic drug, Viagra, triggering questions about the prospects of connected pharmaceutical holdings. While first times saw significant returns, the patent expiration has allowed the door for discounted copies, likely lowering revenue and presenting a significant danger for